About the company AstraZeneca Pharma India Limited is an India-based biopharmaceutical company. Its therapeutic areas include cardiovascular, renal and metabolism; oncology, and respiratory diseases. The Company operates through Healthcare seg
A company profile report for AstraZeneca Pharma India Limited (AZPIL) from publisher Life Science Analytics Inc. is presented, with topics including management profile, company announcements, deals, alliances and product updates.EBSCO_bspAstrazeneca Pharma India Limited Medtrack Company Profile...
以计算AstraZeneca Pharma India的保险结算为例,见下文:计算示例 行业基准分析 板块 上图描述了发展中经济区的板块医疗保健公司保险结算的分布情况。我们分析了超过40家公司,其中39家的数据为有效数据。这些板块公司的平均保险结算为37.026 M,标准差为62.88 M。 AstraZeneca Pharma India的保险结算排名为第-名,处于...
AstraZeneca Pharma India的现价与52周高点的百分比值是87.8%. 查看AstraZeneca Pharma India的现价与52周高点的百分比值趋势、图表等
AstraZeneca Pharma India下一财年的预估预期税后净经营利润(nopat)是1.957十亿。. 查看AstraZeneca Pharma India的预期税后净经营利润(NOPAT) (InvestingPro)趋势、图表等
AstraZeneca Pharma India于资产负债表中没有报告,截至六月 30, 2024止最近一个季度存在有意义的应付再保险费。 下表总结了AstraZeneca Pharma India过去五年的应付再保险费和百分比分析(common size): 财政年度应付再保险费资产资产占比 2020-03-31NA7.064 B0.0% ...
The health challenges of China and Asia offer big opportunities for multinational pharma companies. Cases of chronic diseases, such as diabetes, are on the rise in the region, as are lung, gastric, and liver cancers. China alone is likely t...
India Post Enquiry Medlab Asia & Asia Health Not Confirmed Post Enquiry 02 CTX Lifesciences India Post Enquiry Medlab Asia & Asia Health Not Confirmed Post Enquiry 03 Hoventa Pharma India Post Enquiry Medlab Asia & Asia Health Not Confirmed ...
AstraZeneca Pharma India Limited has received import and market permission in Form CT-20 from the Drugs Controller General of India for selumetinib 10 mg & 25 mg capsule. Selumetinib 10 mg & 25 mg capsule is indicated for treatment of paediatric patients 3 years of age and older with neurofib...
For AstraZeneca, it had also appeared to be a fine way to enter a new market. Although the UK pharma group had promised to provide doses on a non-profit basis for the duration of the pandemic, it was a possible springboard to enter the vaccine business. ...